Archive — US — techcrunch
PNOE’s new face mask wants to make lab-grade breath testing a self-serve affair
PNOĒ is set to launch a self-serve breath testing mask on October 1, allowing users to measure oxygen consumption and carbon dioxide exhalation easily. This portable device, designed for use in gyms and pharmacies, promises accessibility to metabolic testing previously reserved for elite athletes, capturing various biomarkers to guide fitness and nutrition. Despite being a wellness device, it is not FDA-cleared for medical recommendations.
Key points
- PNOĒ's new mask resembles a comic villain's but serves as a breath testing tool.
- Launch date set for October 1; device allows self-administration of tests.
- Traditional metabolic testing required trained operators; new device could democratize access.
- Captures 23 biomarkers, providing insights into fitness and nutrition.
- Not FDA-approved; marketed as a wellness device without medical claims.
- Company aims to expand into fitness centers and pharmacies.
- Raised $22 million so far; profitable with over 100% annual growth.
Why it matters
- The demand for at-home health tech solutions surged during the COVID-19 pandemic.
- In 2025, wearable health technology will be increasingly integrated in consumer and clinical settings.
- Growing interest in longevity is reshaping wellness and healthcare markets.
- Competitors like Apple and Garmin also focus on VO₂ max and metabolic insights.
PNOĒ's innovative breath testing mask promises to make metabolic health assessments accessible, appealing to the growing wellness trend. Its self-serve nature represents a significant shift in fitness technology, potentially expanding the market beyond elite athletes and into everyday users. However, users should remember it is not a medical device.